Login to Your Account

Reliant IPO Seeking $300M To Advance Heart Portfolio

By Randall Osborne

Tuesday, May 24, 2005
In a financing environment that's less than ideal for biotechnology firms, Reliant Pharmaceuticals Inc. is shooting to raise $300 million with its initial public offering, though the company did not specify the number of shares or the price per share. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription